Kadmon

Vertically integrated biopharmaceutical company targeting Autoimmune and Fibrotic Diseases, Oncology, Monogenic Diseases and Metabolic Diseases

placeNew York City, New York, United States calendar_todayFounded 2009 groups127 employees language kadmon.com

Registered entities

Innovation

44 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,401 times.

YearFilings
20158
20168
201710
20189
201910
202012
202111
20228
202312
202420
202515
20264

Investor mix

4 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital125%
Private equity250%
Other / undisclosed125%
Coming soon